+499.5%
MRNA vs APD
+6.0%
+493.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | APD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.0% | -1.3% | -2.0% |
| 7D | +5.5% | -2.2% | +7.7% | +5.9% |
| 30D | +158.7% | +2.1% | +156.6% | +157.2% |
| 3M | +182.1% | +7.2% | +175.0% | +178.9% |
| 6M | +151.8% | +11.2% | +140.6% | +145.1% |
| YTD | +393.6% | +24.4% | +369.2% | +359.4% |
| 1Y | +499.5% | +6.7% | +492.8% | +523.9% |
| All | +499.5% | +6.0% | +493.4% | +523.9% |
Cumulative growth
Daily Returns
Daily percentage return beside APD.
Daily Out/Under-Performance
Portfolio return minus APD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × APD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded APD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling